Preclin Biosystems AG

Swiss Biotech Association

Member

Preclin Biosystems AG offers a comprehensive in vivo preclinical testing platform for the identification and validation of lead candidate therapeutics and mechanism of action (MOA) studies.

Location

Route de la Corniche 4, 1066 Epalinges, Switzerland

Get Directions

Facts & figures

Type of organization

Private company
Year of foundation

2008
Number of employees in Switzerland

1-9

Key business

Core competencies

Platform technologies

You may also be interested in

Perseo pharma AG

Perseo pharma: best-in-class enzyme therapeutics Perseo pharma is a preclinical-stage biotech start-up developing best-in-class enzyme therapeutics based on an innovative proprietary nanotechnology platform.
4057 Basel

Member

Linkster Therapeutics AG

Linkster Therapeutics AG develops novel therapeutic antibodies using our proprietary Flycode® and Sybody® platforms. Our technologies screen antibody properties in high throughput <em>in vivo</em>, thus enabling precise tissue targeting beyond trivial molecular recognition and massively reduce animal trials.
8006 Zürich

Member

Cancer Research and Biotechnology AG

Many cures target the cancer directly or by educating the immune system. The root causes of cancer are often sidelined as importance is given directly to the cancer itself. Thus, tackling the causes and their mode of action leading to cancer, is the aim at Cancer Research and Biotechnology AG.
CH-6340 Baar (Zug)

Member